Caris Life Sciences (CAI) Goodwill & Intangibles (2024 - 2026)
Caris Life Sciences' (CAI) quarterly Goodwill & Intangibles came in at $19.3 million in Q1 2026, little changed quarter-over-quarter from $19.3 million in Q4 2025.
Caris Life Sciences (CAI) Goodwill & Intangibles (2024 - 2026) Analysis & Trends
Caris Life Sciences' Goodwill & Intangibles history runs 3 years deep, the most recent figure standing at $19.3 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $19.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $19.3 million, changed 0.0% from the prior year.
- Goodwill & Intangibles was little changed at $19.3 million in Q1 2026 per CAI's latest filing, from $19.3 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $19.3 million in Q4 2024 and bottomed at $19.3 million in Q4 2024.
- The 3-year median for Goodwill & Intangibles is $19.3 million (2024), against an average of $19.3 million.
- Biggest YoY gain for Goodwill & Intangibles was 0.0% in 2025; the steepest drop was 0.0% in 2025.
- Year by year, Goodwill & Intangibles stood at $19.3 million in 2024, then changed by 0.0% to $19.3 million in 2025, then changed by 0.0% to $19.3 million in 2026.
- Per Business Quant, the three latest CAI Goodwill & Intangibles figures stand at $19.3 million (Q1 2026), $19.3 million (Q4 2025), and $19.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Caris Life Sciences | 4.47 Bn | 3.65 Bn | 214.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.34 Mn |
| Dec 31, 2025 | 19.34 Mn |
| Sep 30, 2025 | 19.34 Mn |
| Jun 30, 2025 | 19.34 Mn |
| Dec 31, 2024 | 19.34 Mn |